Cargando…
microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer
microRNA-217 (miR-217) is frequently dysregulated in cancer. Here, we report that miR-217 levels were lower in tumor tissue compared with the adjacent normal tissue. Low levels of miR-217 were associated with aggressive tumor phenotypes and poor overall survival in gastric cancer patients. The ectop...
Autores principales: | Chen, Dong-liang, Zhang, Dong-sheng, Lu, Yun-xin, Chen, Le-zong, Zeng, Zhao-lei, He, Ming-ming, Wang, Feng-hua, Li, Yu-hong, Zhang, Hui-zhong, Pelicano, Helene, Zhang, Wei, Xu, Rui-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484425/ https://www.ncbi.nlm.nih.gov/pubmed/25869101 |
Ejemplares similares
-
Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma
por: Peng, Hong-hua, et al.
Publicado: (2013) -
MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2
por: Sun, Xin-bo, et al.
Publicado: (2021) -
The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5
por: Wang, Hui, et al.
Publicado: (2015) -
Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression
por: Chen, Dong-liang, et al.
Publicado: (2016) -
Correction to: Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression
por: Chen, Dong-liang, et al.
Publicado: (2021)